Showing results (291-300 of 554) with videos related to

Sort By:
Pageof 56
Cancers|May 14, 2025
Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated CancersCatherine H Marshall, Ali T Arafa, Ellen Jaeger, et al.
European Urology|August 19, 2025
The Role of Liquid Biopsy in the Management of Patients with Genitourinary MalignanciesBenjamin L Maughan, Lars Dyrskjøt, Petros Grivas, et al.
European Urology|February 25, 2019
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM MutationsCatherine H Marshall, Alexandra O Sokolova, Andrea L McNatty, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
The Oncologist|June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutationsMark C Markowski, Cora N Sternberg, Hao Wang, et al.
International Journal of Neurology|January 1, 1991
A molecular genetic approach to amyotrophic lateral sclerosisT Siddique, P Hu, A Hentati, et al.
Clinical Genitourinary Cancer|July 23, 2023
Case Series of Men with the Germline APC I1307K variant and Treatment-Emergent Neuroendocrine Prostate CancerMinas P Economides, Mari Nakazawa, Jonathan W Lee, et al.
Genomics|May 1, 1993
The CEPH consortium linkage map of human chromosome 13A M Bowcock, S C Gerken, R I Barnes, et al.
JCO Precision Oncology|May 17, 2023
MLH1 Loss in Primary Prostate CancerSanaz Nourmohammadi Abadchi, Laura A Sena, Emmanuel S Antonarakis, et al.
European Urology|April 21, 2018
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision OncologyPhilipp Nuhn, Johann S De Bono, Karim Fizazi, et al.
Pageof 56